Anadys Pharmaceuticals Inc. (Nasdaq: ANDS) 15.6% LOWER; reports Q4 loss of $0.11, 6 cents better than the analyst estimate of ($0.17).

Polypore International Inc. (NYSE: PPO) 14.7% HIGHER; reports Q4 EPS of $0.36, ex-items, versus the analyst estimate of $0.17. Revenue for the quarter was $152 million, which compares to the estimate of $135.09 million.

PC Mall Inc. (Nasdaq: MALL) 13.7% LOWER; reports prelim. Q4 EPS of $0.01, 16 cents below the analyst estimate of $0.17. Revenue for the quarter was $337 million, which compares to the estimate of $313.6 million. Commenting on the Company’s fourth quarter results, Frank